Targeting Th9 cells in autoimmune diseases: a narrative review

靶向Th9细胞治疗自身免疫性疾病:综述

阅读:2

Abstract

T helper 9 (Th9) cells are a newly identified subset of effector T cells, characterized by their production of IL-9, a hallmark cytokine. Transcription factors such as PU.1 and IRF4 bind to the IL9 gene promoter and transactivate its expression. IL-9 and its associated transcription factors regulate various aspects of Th9 cell biology, including proliferation, apoptosis, differentiation, and interactions with other immune cells through downstream signaling pathways. In recent years, the involvement of Th9 cells in autoimmune diseases has been widely investigated. Multiple studies have reported the aberrant expression of IL-9, PU.1, and IRF4 in these inflammatory conditions, and functional analyses have demonstrated their significant roles in disease development. In this review, we comprehensively summarize the relationship among Th9-related cytokines, transcription factors, and 14 autoimmune diseases based on both in vivo and in vitro evidence. We further discuss the regulatory effects of intracellular and extracellular signaling pathways on Th9 cell functions. This compilation of findings may facilitate future research and the development of clinical strategies targeting Th9 cells in autoimmune diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。